341 related articles for article (PubMed ID: 32207235)
21. Long non‑coding RNA HOTTIP enhances the fibrosis of lung tissues by regulating the miR‑744‑5p/PTBP1 signaling axis.
Li J; Chai W; Zhao Z; Zhou Y; Wu Q
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34212978
[TBL] [Abstract][Full Text] [Related]
22. Cancer-Specific Energy Metabolism in Rhabdomyosarcoma Cells Is Regulated by MicroRNA.
Sugito N; Taniguchi K; Kuranaga Y; Ohishi M; Soga T; Ito Y; Miyachi M; Kikuchi K; Hosoi H; Akao Y
Nucleic Acid Ther; 2017 Dec; 27(6):365-377. PubMed ID: 28981396
[TBL] [Abstract][Full Text] [Related]
23. HSP90AA1-mediated autophagy promotes drug resistance in osteosarcoma.
Xiao X; Wang W; Li Y; Yang D; Li X; Shen C; Liu Y; Ke X; Guo S; Guo Z
J Exp Clin Cancer Res; 2018 Aug; 37(1):201. PubMed ID: 30153855
[TBL] [Abstract][Full Text] [Related]
24. Circular RNA circRHOBTB3 represses metastasis by regulating the HuR-mediated mRNA stability of PTBP1 in colorectal cancer.
Chen J; Wu Y; Luo X; Jin D; Zhou W; Ju Z; Wang D; Meng Q; Wang H; Fu X; Xu J; Song Z
Theranostics; 2021; 11(15):7507-7526. PubMed ID: 34158864
[No Abstract] [Full Text] [Related]
25. LncRNA NORAD targets miR-410-3p to regulate drug resistance sensitivity of osteosarcoma.
Xie X; Liu W; Duan Z; Li X; Zhang L; Yang G
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):143-148. PubMed ID: 32538761
[TBL] [Abstract][Full Text] [Related]
26. PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors.
Taniguchi K; Sakai M; Sugito N; Kumazaki M; Shinohara H; Yamada N; Nakayama T; Ueda H; Nakagawa Y; Ito Y; Futamura M; Uno B; Otsuki Y; Yoshida K; Uchiyama K; Akao Y
Oncotarget; 2016 Apr; 7(14):18940-52. PubMed ID: 26980745
[TBL] [Abstract][Full Text] [Related]
27. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA LARP4 correlates with decreased Enneking stage, better histological response, and prolonged survival profiles, and it elevates chemosensitivity to cisplatin and doxorubicin via sponging microRNA-424 in osteosarcoma.
Hu Y; Gu J; Shen H; Shao T; Li S; Wang W; Yu Z
J Clin Lab Anal; 2020 Feb; 34(2):e23045. PubMed ID: 31642110
[TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
[TBL] [Abstract][Full Text] [Related]
30. A miR-194/PTBP1/CCND3 axis regulates tumor growth in human hepatocellular carcinoma.
Kang H; Heo S; Shin JJ; Ji E; Tak H; Ahn S; Lee KJ; Lee EK; Kim W
J Pathol; 2019 Nov; 249(3):395-408. PubMed ID: 31301177
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of BMI-1 promotes cell growth and resistance to cisplatin treatment in osteosarcoma.
Wu Z; Min L; Chen D; Hao D; Duan Y; Qiu G; Wang Y
PLoS One; 2011 Feb; 6(2):e14648. PubMed ID: 21311599
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effect of MSH6 gene silencing in combination with cisplatin on cell proliferation of human osteosarcoma cell line MG63.
Liu HC; Zeng J; Zhang B; Liu XQ; Dai M
J Cell Physiol; 2019 Jun; 234(6):9358-9369. PubMed ID: 30456894
[TBL] [Abstract][Full Text] [Related]
33. LncRNA SFTA1P promotes cervical cancer progression by interaction with PTBP1 to facilitate TPM4 mRNA degradation.
Luo A; Lan X; Qiu Q; Zhou Q; Li J; Wu M; Liu P; Zhang H; Lu B; Lu Y; Lu W
Cell Death Dis; 2022 Nov; 13(11):936. PubMed ID: 36344495
[TBL] [Abstract][Full Text] [Related]
34. TGM2 knockdown reverses cisplatin chemoresistance in osteosarcoma.
Li C; Cai J; Ge F; Wang G
Int J Mol Med; 2018 Oct; 42(4):1799-1808. PubMed ID: 30015899
[TBL] [Abstract][Full Text] [Related]
35. Effect of lncRNA ANRIL knockdown on proliferation and cisplatin chemoresistance of osteosarcoma cells in vitro.
Li G; Zhu Y
Pathol Res Pract; 2019 May; 215(5):931-938. PubMed ID: 30777616
[TBL] [Abstract][Full Text] [Related]
36. Anticancer potential of TUG1 knockdown in cisplatin-resistant osteosarcoma through inhibition of MET/Akt signalling.
Zhou Q; Hu T; Xu Y
J Drug Target; 2020 Feb; 28(2):204-211. PubMed ID: 31305159
[TBL] [Abstract][Full Text] [Related]
37. miR-340 alleviates chemoresistance of osteosarcoma cells by targeting ZEB1.
Yan H; Zhang B; Fang C; Chen L
Anticancer Drugs; 2018 Jun; 29(5):440-448. PubMed ID: 29494357
[TBL] [Abstract][Full Text] [Related]
38. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
[TBL] [Abstract][Full Text] [Related]
39. CircFAM120B knockdown inhibits osteosarcoma tumorigenesis via the miR-1205/PTBP1 axis.
Li JJ; Xiong MY; Sun TY; Ji CB; Guo RT; Li YW; Guo HY
Aging (Albany NY); 2021 Oct; 13(20):23831-23841. PubMed ID: 34716285
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA ROR regulated ABCB1 to induce cisplatin resistance in osteosarcoma by sponging miR-153-3p.
Cheng FH; Zhao ZS; Liu WD
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(17):7256-7265. PubMed ID: 31539112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
